Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia

AIMS: The aim of the phase Ib, two part SAWYER study (BO25341; NCT01292603) was to investigate the pharmacokinetics and safety of subcutaneous (s.c.) rituximab compared with intravenous (i.v.) rituximab, both in combination with fludarabine and cyclophosphamide (FC), as first line treatment for pati...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Br J Clin Pharmacol
Main Authors: Assouline, Sarit, Buccheri, Valeria, Delmer, Alain, Gaidano, Gianluca, McIntyre, Christine, Brewster, Michael, Catalani, Olivier, Hourcade-Potelleret, Florence, Sayyed, Pakeeza, Badoux, Xavier
Formáid: Artigo
Teanga:Inglês
Foilsithe: John Wiley & Sons, Ltd 2015
Ábhair:
Clinical Trials
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631173/
https://ncbi.nlm.nih.gov/pubmed/25900065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12662
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla